A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 269
Comprehensive Pages
- 8
Geographic and Economic Breakouts
- 5
Year Market Forecasts
- 52
Diseases Analyzed
2025 Cornea Products Market Report: Global Analysis for 2024 to 2030, December, 2025
The “2025 Cornea Products Market Report” delivers an in-depth analysis of the global cornea market, highlighting the latest advances in transplantation, crosslinking, and therapeutic devices aimed at restoring and preserving vision. The report estimates disease prevalence across six major corneal conditions and examines evolving treatment approaches, including cornea transplants, therapeutic lenses, phototherapeutic keratectomy (PTK), intrastromal ring segments, and corneal crosslinking.
It also explores the global ecosystem that supports cornea care—spanning organ donation systems, regulatory environments, and the pivotal roles of cornea specialists, eye banks, and nonprofit organizations.
This 2025 edition evaluates more than 70 products from over 50 companies, with forecasts for unit demand and revenue growth through 2030. It features analysis of emerging pipeline technologies yet to generate revenue and profiles 12 leading market participants shaping the future of cornea treatment.
Latest Industry News & Trends
5/14/2026
ASCRSCataractIOLMeetingNewsletterRefractive
2026 ASCRS Meeting Adds Patriotic Pomp, Lighter Features to Program
A wave of IOL launches dominated the 2026 meeting of the American Society of Cataract and Refractive Surgery (ASCRS), highlighting intensifying competition across the premium IOL space. But confere...
5/14/2026
ASCRSCataractIOLMeetingNewsletter
IOL Makers Go All in to Launch Premium Lenses at ASCRS Meeting
Johnson & Johnson Vision, BVI Medical, and Alcon showcased the strengths of their latest IOLs throughout the 2026 ASCRS meeting, explaining how their technology benefits the growing premium space. ...
5/14/2026
GlaucomaNewsletterPharma
Generics, New Drug Classes, Sustained Release Dosing Shape Glaucoma Pharma Market
The glaucoma pharmaceuticals market is showing signs of emerging from its prolonged revenue slump. One cycle of conversions from proprietary drugs to generic drugs is nearing an end, and a new cycl...
5/14/2026
MyopiaNewsletterRefractive
Myopia Management Market Poised for Growth with Recent Product Advancements
Recent moves by eye care companies suggest that the myopia management market is entering a new phase. In September 2025, Essilor gained US marketing authorization for the Stellest, the first specta...
5/14/2026
AcquisitionsDealsGlaucomaNewsletterRetina
Bayer to Acquire Perfuse in Deal Worth Up to $2.45 Billion
German drugmaker Bayer announced May 6 that it would acquire Perfuse Therapeutics in a deal worth up to $2.45 billion. Perfuse, of South San Francisco, California, is advancing PER-001 for glaucoma...
5/14/2026
AcquisitionsDealsDiagnosticNewsletter
Revenio Group to Acquire Visionix in $341 Million Deal
Finland’s Revenio Group, parent of ophthalmic diagnostic company iCare, announced April 13 that it would acquire France-based Visionix in a deal worth €290 million ($341 million). Revenio said that...
5/14/2026
DiagnosticDry EyeGlaucomaNewsletterRegulation
Select US FDA Approvals and Clearances in April 2026
The US FDA’s ophthalmic device division granted clearance to four devices using the 510(k) pathway in April 2026, according to the agency’s database. Retmap received clearance for its RM Electrode,...
5/14/2026
NewsletterPresbyopiaThyroid Eye Disease
PDUFA Dates for Ophthalmic Drug Candidates
The US FDA has scheduled the following Prescription Drug User Fee Act (PDUFA) target action dates for ophthalmic drug, drug/device, and biologic candidates.
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.